查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941784

美國呼吸系統耐用醫療設備市場規模、佔有率和趨勢分析報告：按產品供應、分銷/服務管道、主要州和細分市場預測，2026-2033年

U.S. Respiratory Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product Offering, By Distribution & Service Channel, By Notable States, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 330 Pages | 商品交期: 2-10個工作天內

價格

美國呼吸系統耐用醫療設備市場概述

預計到 2025 年，美國呼吸系統 DME 市場價值將達到 40.1 億美元，到 2033 年將達到 58.9 億美元。

預計從 2026 年到 2033 年，該市場將以 4.93% 的複合年成長率成長。這一成長歸功於小型化、高效能攜帶式氧氣濃縮機、改進的非侵入性家用人工呼吸器和連網 PAP 呼吸機的技術進步。

此外，中西部許多州慢性呼吸系統疾病（尤其是慢性阻塞性肺病及其相關併發症）的高發生率，加上人口老化、更多人用戶聯邦醫療保險（Medicare）以及大規模傾向於居家照護的農村患者，共同導致了對制氧機、攜帶式氧氣系統和家用人工呼吸器的持續需求。中西部地區慢性呼吸系統疾病（包括慢性阻塞性肺病、氣喘和睡眠呼吸障礙）的盛行率相對較高，這主要是由於人口老化以及某些州吸菸率較高所致。

根據美國肺臟協會統計，到2023年，美國約有1,110萬成年人將患有慢性阻塞性肺病（COPD），該疾病仍然是導致發病率和死亡率的主要原因之一，每年造成約500億美元的醫療保健費用。 COPD日益嚴重的負擔，以及患者需要使用非侵入性通氣來控制高碳酸血症、急性加重和睡眠呼吸障礙，都推動了家用和醫院用雙水平氣道正壓通氣（BiPAP）/持續氣道正壓通氣（VPAP）設備的需求。

俄亥俄州、密西根州、印第安納州、伊利諾伊州和密蘇裡州等州的慢性阻塞性肺病（COPD）和阻塞型睡眠呼吸中止症症（OSA）發病率顯著較高，這直接推高了對氧氣濃縮機、持續性氣道正壓通氣（CPAP）/雙水平氣道正壓通氣（BiPAP）機、持續性氣道正壓通氣（CPAP）/雙水平氣道正壓通氣（BiPAP）機、持續性呼吸器和輔助通氣設備的需求。此外，該地區人口老化導致越來越多的老年人在出院後需要長期呼吸支持和復健護理設備，加速了這些設備的普及。

此外，中西部地區醫療系統、醫院和支付方高度重視居家照護和成本控制，這正推動呼吸系統護理從住院環境向居家環境的積極轉變，以減少住院時間和避免再入院罰款。這導致長期氧氣療法、睡眠治療設備以及具備遠端患者監護功能的呼吸設備對耐用醫療設備（DME）供應商的依賴性增強。這一趨勢主要受聯邦醫療保險/醫療補助計劃（Medicare/Medicaid）報銷機制的推動，該機制鼓勵使用居家氧氣療法和睡眠治療，尤其是在中西部地區以農村和半都市區。此外，中西部地區聯邦醫療保險受益人比例相對較高，因此聯邦報銷政策也是呼吸系統耐用醫療設備需求的重要促進因素。

例如，內布拉斯加州的支付模式反映了都市區混合人口的呼吸系統特徵，其中呼吸機的使用主要依賴醫療補助計劃（Medicaid）。這是因為年輕人的睡眠呼吸中止症發生率高於65歲以上。聯邦醫療保險（Medicare）仍佔有相當大的比例，但由於其主要服務於老年慢性阻塞性肺病（COPD）患者，因此其使用比例較低。同時，氧氣濃縮機、人工呼吸器和霧化器也高度依賴聯邦醫療保險，這與內布拉斯加州COPD和慢性呼吸系統疾病患者群體老化，且老年人依賴聯邦醫療保險的情況相符。私人保險比例較低是因為商業保險在農村地區的普及率較低。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 美國呼吸系統耐用醫療設備市場：按產品供應情況分類的估算和趨勢分析

  • 按產品供應情況分類的波動分析和市佔率分析（2024 年和 2033 年）
  • 按產品類型分類的美國呼吸系統耐用醫療設備 (DME) 市場規模估計和預測
    • 睡眠呼吸中止症治療設備
    • 氧氣療法
    • 霧化治療設備
    • 口罩、導管、過濾器、耗材
    • 家用和運輸用人工呼吸器

第4章 美國呼吸系統耐用醫療設備市場：分銷和服務管道的估算和趨勢分析

  • 分銷和服務管道波動分析及市場佔有率分析（2024 年和 2033 年）
  • 美國呼吸系統DME市場規模按分銷和服務管道分類的估算和預測
    • 全國性DME網路
    • 當地獨立人士
    • 醫院/家庭護理擴展
    • 線上耐用醫療設備零售商

5. 區域/州級：依細分市場分類，2021-2033 年

  • 中西部
    • 內布拉斯加州
    • 愛荷華州
    • 堪薩斯州
    • 南達科他州
    • 北達科他州
    • 密蘇裡州
    • 明尼蘇達州
    • 威斯康辛州
    • 伊利諾州
    • 科羅拉多
    • 懷俄明州
    • 俄亥俄州
    • 印第安納州

第6章 競爭分析

  • 參與企業概況
    • 一級（國家耐用醫療設備供應商）
    • 二級供應商（OEM）
    • 第三級（本地獨立商家）
  • 財務業績
    • 一級（國家耐用醫療設備供應商）
    • 二級供應商（OEM）
    • 第三級（本地獨立商家）
  • 產品基準測試
    • 一級（國家耐用醫療設備供應商）
    • 二級供應商（OEM）
    • 第三級（本地獨立商家）
  • 參與企業
  • 企業市場分析
    • 一級（國家耐用醫療設備供應商）
    • 二級供應商（OEM）
    • 第三級（本地獨立商家）
  • 現有市場參與者的退出策略及其對市場競爭對手的影響
    • Medical Depot, Inc. Dba Drive Devilbiss Healthcare
    • Philips Respironics
    • Fisher & Paykel Healthcare
    • Invacare
    • Resmed
    • Medtronic
    • Teleflex Incorporated
    • Breas Medical AB
  • 策略規劃
    • 一級（國家耐用醫療設備供應商）
    • 二級供應商（OEM）
    • 第三級（本地獨立商家）
  • 其他市場參與者名單
Product Code: GVR-4-68040-845-6

U.S. Respiratory Durable Medical Equipment Market Summary

The U.S. respiratory durable medical equipment (DME) market size was valued at USD 4.01 billion in 2025 and is projected to reach USD 5.89 billion by 2033, growing at a CAGR of 4.93% from 2026 to 2033. This growth is attributed to the technological advances smaller, more efficient portable oxygen concentrators, improved non-invasive home ventilators and connected PAP machines.

In addition, higher chronic respiratory disease prevalence (notably COPD and related comorbidities) in many Midwestern states together with an older, Medicare-heavy population and large rural patient cohorts who prefer home-based care, creates enduring demand for concentrators, portable oxygen systems and home ventilators. The Midwest has a comparatively higher prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep-disordered breathing, largely due to an aging population and higher smoking prevalence in certain states.

According to the American Lung Association, in 2023, approximately 11.1 million adults in the United States are living with COPD, which remains a leading cause of morbidity and mortality and is associated with an estimated USD 50 billion in annual healthcare costs. The increasing burden of COPD, combined with the need for non-invasive ventilation to manage hypercapnia, acute exacerbations, and sleep-disordered breathing in these patients, has fueled demand for home and hospital-based BiPAP/VPAP devices.

States such as Ohio, Michigan, Indiana, Illinois, and Missouri report a significant burden of COPD and obstructive sleep apnea (OSA), directly supporting demand for oxygen concentrators, CPAP/BiPAP devices, nebulizers, and ventilatory support equipment. The region's aging demographic profile further accelerates adoption, as older adults are more likely to require long-term respiratory support and post-acute care equipment following hospital discharge.

Moreover, the strong emphasis on home-based care and cost containment across Midwestern healthcare systems, hospitals, and payers is actively shifting respiratory care from inpatient to home settings to reduce length of stay and readmission penalties, increasing reliance on DME providers for long-term oxygen therapy, sleep therapy devices, and remote patient monitoring-enabled respiratory equipment. This trend is fueled by Medicare and Medicaid reimbursement structures, which incentivize home oxygen and sleep therapy utilization, particularly in rural and semi-urban areas that characterize much of the Midwest. In addition, the Midwest has a relatively high proportion of Medicare beneficiaries, making federal reimbursement policies a critical demand driver for respiratory DME volumes.

For instance, Nebraska's payer pattern reflects a mixed urban-rural respiratory profile, where PAP devices tilt toward Medicaid because sleep apnea incidence is higher in the adult, non-elderly population than in the 65+ group. Medicare still contributes substantially but remains secondary as its coverage primarily captures older COPD-dominant cohorts. However, oxygen concentrators, ventilators, and nebulizers lean strongly toward Medicare, consistent with Nebraska's aging COPD and chronic respiratory population that relies more on federal senior coverage. Private plans track smaller shares due to lower employer-sponsored penetration in rural counties.

U.S. Respiratory Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. respiratory durable medical equipment (DME) market report based on product offerings, distribution & service channel, and Midwest states:

  • Product Offerings Outlook (Revenue, USD Million, 2021 - 2033)
  • Sleep Apnea Devices
    • Auto-titrating CPAP (APAP)
    • Fixed CPAP
    • BiPAP / VPAP
    • Integrated Humidifiers
  • Oxygen Therapy
    • Stationary Oxygen Concentrators
    • Portable Oxygen Concentrators (POCs)
    • Cylinders & Regulators
    • Conservers
  • Nebulizer Equipment
    • Compressor Nebulizers
    • Mesh Nebulizers
    • Drug-specific nebulizers
  • Home & Transport Ventilators
    • Adult/pediatric long-term home ventilators
    • Portable Transport Ventilators
  • Masks, Tubing, Filters & Resupply Items (Consumables)
    • CPAP masks
    • CPAP cushions
    • Oxygen tubing & filters
    • Humidifier chambers
    • Bacterial/viral filters
    • Aerosol delivery accessories
  • Distribution & Service Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • National DME Networks
  • Regional Independents
  • Hospital/IDN Homecare Extensions
  • Online DME Retailers
  • Notable States (Midwest Only) Outlook (Revenue, USD Million, 2021 - 2033)
  • Nebraska (NE)
  • Iowa (IA)
  • Kansas (KS)
  • South Dakota (SD)
  • North Dakota (ND)
  • Missouri (MO)
  • Minnesota (MN)
  • Wisconsin (WI)
  • Illinois (IL)
  • Colorado (CO)
  • Wyoming (WY)
  • Ohio (OH)
  • Indiana (IN)

Table of Contents

Chapter 1 Research Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Objectives
    • 1.2.1 Objective - 1
    • 1.2.2 Objective - 2
    • 1.2.3 Objective - 3
  • 1.3 List of Secondary Sources
  • 1.4 List of Abbreviation

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Product and End Use Outlook
  • 2.3 Competitive Landscape

Chapter 3 U.S. Respiratory Durable Medical Equipment Market: Product Offering Estimates & Trend Analysis

  • 3.1 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
  • 3.2 Product Offering Movement & Market Share Analysis, 2024 & 2033
  • 3.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Product Offering
    • 3.3.1 Sleep Apnea Devices
      • 3.3.1.1 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
      • 3.3.1.2 Auto-titrating CPAP
      • 3.3.1.3 Fixed CPAP
      • 3.3.1.4 BiPAP/VPAP (S/T, AVAPS)
      • 3.3.1.5 Integrated Humidifiers
    • 3.3.2 Oxygen Therapy
      • 3.3.2.1 Oxygen Therapy Market, 2021 - 2033 (USD Million)
      • 3.3.2.2 Stationary Oxygen Concentrators
      • 3.3.2.3 Portable Oxygen Concentrators (POCs)
      • 3.3.2.4 Cylinders & regulators
      • 3.3.2.5 Conservers
    • 3.3.3 Nebulizer Therapy Equipment
      • 3.3.3.1 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
      • 3.3.3.2 Compressor nebulizers
      • 3.3.3.3 Mesh Nebulizers
      • 3.3.3.4 Drug-specific Nebulizers
    • 3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 3.3.4.1 Masks, Tubing, Filters & Resupply Items (Consumables) Market, 2021 - 2033 (USD Million)
      • 3.3.4.2 CPAP Masks & Cushions
      • 3.3.4.3 Oxygen tubing & filters
      • 3.3.4.4 Humidifier Chambers
      • 3.3.4.5 Bacterial/Viral (B/V)
      • 3.3.4.6 Aerosol Delivery Accessories
    • 3.3.5 Home & Transport Ventilators
      • 3.3.5.1 Home & Transport Ventilatorsmarket, 2021 - 2033 (USD Million)
      • 3.3.5.2 Adult/Pediatric Long-Term Home Ventilators
      • 3.3.5.3 Portable Ventilators (Transport/ALS)

Chapter 4 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Estimates & Trend Analysis

  • 4.1 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
  • 4.2 Distribution & Service Channels Movement & Market Share Analysis, 2024 & 2033
  • 4.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Distribution & Service Channels
    • 4.3.1 National Dme Networks
      • 4.3.1.1 National DME Networks market, 2021 - 2033 (USD Million)
    • 4.3.2 Regional Independents
      • 4.3.2.1 Regional Independents Market, 2021 - 2033 (USD Million)
    • 4.3.3 Hospital/Idn Homecare Extensions
      • 4.3.3.1 Hospital/IDN Homecare Extensions Market, 2021 - 2033 (USD Million)
    • 4.3.4 Online Dme Retailers
      • 4.3.4.1 Online DME Retailers Market, 2021 - 2033 (USD Million)

Chapter 5 Regional/State-Level Quantified Deliverables, by Segment, 2021 - 2033, (Revenue, USD Million)

  • 5.1 Midwest
    • 5.1.1 Nebraska
      • 5.1.1.1 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.1.2 Demand & Patient Population
        • 5.1.1.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.1.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.1.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.1.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.1.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.1.3 Supplier Density & Network Mapping
      • 5.1.1.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.1.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.1.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.1.5.1 Sleep Clinics
        • 5.1.1.5.2 Pulmonologists
        • 5.1.1.5.3 Hospitals
        • 5.1.1.5.4 Other providers
      • 5.1.1.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.1.7 Research Methodology
    • 5.1.2 IOWA
      • 5.1.2.1 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.2.2 Demand & Patient Population
        • 5.1.2.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.2.2.2 Utilization and healthcare service demand metrics, by sleep apnea devices
        • 5.1.2.2.3 Utilization and healthcare service demand metrics, by nebulizers equipment
        • 5.1.2.2.4 Utilization and healthcare service demand metrics, by home & transport ventilators
        • 5.1.2.2.5 Utilization and healthcare service demand metrics, by oxygen therapy
      • 5.1.2.3 Supplier Density & Network Mapping
      • 5.1.2.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.2.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.2.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.2.5.1 Sleep Clinics
        • 5.1.2.5.2 Pulmonologists
        • 5.1.2.5.3 Hospitals
        • 5.1.2.5.4 Other providers
      • 5.1.2.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.2.1 Research Methodology
    • 5.1.3 KANSAS
      • 5.1.3.1 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.3.2 Demand & Patient Population
        • 5.1.3.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.3.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.3.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.3.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.3.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.3.3 Supplier Density & Network Mapping
      • 5.1.3.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.3.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.3.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.3.5.1 Sleep Clinics
        • 5.1.3.5.2 Pulmonologists
        • 5.1.3.5.3 Hospitals
        • 5.1.3.5.4 Other providers
      • 5.1.3.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.3.7 Research Methodology
    • 5.1.4 SOUTH DAKOTA
      • 5.1.4.1 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.4.2 Demand & Patient Population
        • 5.1.4.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.4.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.4.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.4.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.4.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.4.3 Supplier Density & Network Mapping
      • 5.1.4.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.4.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.4.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.4.5.1 Sleep Clinics
        • 5.1.4.5.2 Pulmonologists
        • 5.1.4.5.3 Hospitals
        • 5.1.4.5.4 Other providers
      • 5.1.4.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.4.7 Research Methodology
    • 5.1.5 North Dakota
      • 5.1.5.1 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.5.2 Demand & Patient Population
        • 5.1.5.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.5.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.5.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.5.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.5.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.5.3 Supplier Density & Network Mapping
      • 5.1.5.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.5.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.5.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.5.5.1 Sleep Clinics
        • 5.1.5.5.2 Pulmonologists
        • 5.1.5.5.3 Hospitals
        • 5.1.5.5.4 Other providers
      • 5.1.5.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.5.7 Research Methodology
    • 5.1.6 Missouri
      • 5.1.6.1 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.6.2 Demand & Patient Population
        • 5.1.6.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.6.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.6.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.6.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.6.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.6.3 Supplier Density & Network Mapping
      • 5.1.6.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.6.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.6.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.6.5.1 Sleep Clinics
        • 5.1.6.5.2 Pulmonologists
        • 5.1.6.5.3 Hospitals
        • 5.1.6.5.4 Other providers
      • 5.1.6.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.6.7 Research Methodology
    • 5.1.7 Minnesota
      • 5.1.7.1 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.7.2 Demand & Patient Population
        • 5.1.7.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.7.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.7.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.7.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.7.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.7.3 Supplier Density & Network Mapping
      • 5.1.7.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.7.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.7.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.7.5.1 Sleep Clinics
        • 5.1.7.5.2 Pulmonologists
        • 5.1.7.5.3 Hospitals
        • 5.1.7.5.4 Other providers
      • 5.1.7.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.7.7 Research Methodology
    • 5.1.8 Wisconsin
      • 5.1.8.1 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.8.2 Demand & Patient Population
        • 5.1.8.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.8.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.8.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.8.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.8.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.8.3 Supplier Density & Network Mapping
      • 5.1.8.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.8.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.8.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.8.5.1 Sleep Clinics
        • 5.1.8.5.2 Pulmonologists
        • 5.1.8.5.3 Hospitals
        • 5.1.8.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.8.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.8.7 Research Methodology
    • 5.1.9 Illinois
      • 5.1.9.1 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.9.2 Demand & Patient Population
        • 5.1.9.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.9.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.9.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.9.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.9.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.9.3 Supplier Density & Network Mapping
      • 5.1.9.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.9.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.9.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.9.5.1 Sleep Clinics
        • 5.1.9.5.2 Pulmonologists
        • 5.1.9.5.3 Hospitals
        • 5.1.9.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.9.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.9.7 Research Methodology
    • 5.1.10 Colorado
      • 5.1.10.1 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.10.2 Demand & Patient Population
        • 5.1.10.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.10.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.10.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.10.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.10.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.10.3 Supplier Density & Network Mapping
      • 5.1.10.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.10.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.10.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.10.5.1 Sleep Clinics
        • 5.1.10.5.2 Pulmonologists
        • 5.1.10.5.3 Hospitals
        • 5.1.10.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.10.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.10.7 Research Methodology
    • 5.1.11 WYOMING
      • 5.1.11.1 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.11.2 Demand & Patient Population
        • 5.1.11.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.11.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.11.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.11.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.11.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.11.3 Supplier Density & Network Mapping
      • 5.1.11.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.11.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.11.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.11.5.1 Sleep Clinics
        • 5.1.11.5.2 Pulmonologists
        • 5.1.11.5.3 Hospitals
        • 5.1.11.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.11.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.11.7 Research Methodology
    • 5.1.12 OHIO
      • 5.1.12.1 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.12.2 Demand & Patient Population
        • 5.1.12.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.12.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.12.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.12.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.12.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.12.3 Supplier Density & Network Mapping
      • 5.1.12.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.12.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.12.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.12.5.1 Sleep Clinics
        • 5.1.12.5.2 Pulmonologists
        • 5.1.12.5.3 Hospitals
        • 5.1.12.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.12.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.12.7 Research Methodology
    • 5.1.13 INDIANA
      • 5.1.13.1 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.13.2 Demand & Patient Population
        • 5.1.13.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.13.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.13.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.13.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.13.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.13.3 Supplier Density & Network Mapping
      • 5.1.13.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.13.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.13.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.13.5.1 Sleep Clinics
        • 5.1.13.5.2 Pulmonologists
        • 5.1.13.5.3 Hospitals
        • 5.1.13.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.13.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.13.7 Research Methodology

Chapter 6 Competitive Analysis

  • 6.1 Participant's Overview
    • 6.1.1 Tier 1 (National DME Providers)
    • 6.1.2 Tier 2 (OEM Manufacturers)
    • 6.1.3 Tier 3 (Regional Independents)
  • 6.2 Financial Performance
    • 6.2.1 Tier 1 (National DME Providers)
      • 6.2.1.1 Public Companies
      • 6.2.1.2 Private Companies
    • 6.2.2 Tier 2 (OEM Manufacturers)
      • 6.2.2.1 Public Companies
      • 6.2.2.2 Private Companies
    • 6.2.3 Tier 3 (Regional Independents)
      • 6.2.3.1 Private Companies
  • 6.3 Product Benchmarking
    • 6.3.1 Tier 1 (National DME Providers)
      • 6.3.1.1 Sleep Apnea Devices
      • 6.3.1.2 Oxygen Therapy
        • 6.3.1.2.1 Portable Oxygen Concentrators
        • 6.3.1.2.2 Stationary Oxygen Concentrators
      • 6.3.1.3 Nebulizer Therapy Equipment
      • 6.3.1.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 6.3.1.5 Home & Transport Ventilators
    • 6.3.2 Tier 2 (OEM Manufacturers)
      • 6.3.2.1 Sleep Apnea Devices
      • 6.3.2.2 Oxygen Therapy
        • 6.3.2.2.1 Portable Oxygen Concentrators
        • 6.3.2.2.2 Stationary Oxygen Concentrators
      • 6.3.2.3 Nebulizer Therapy Equipment
      • 6.3.2.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 6.3.2.5 Home & Transport Ventilators
    • 6.3.3 Tier 3 (Regional Independents)
      • 6.3.3.1 Sleep Apnea Devices
      • 6.3.3.2 Oxygen Therapy
        • 6.3.3.2.1 Portable Oxygen Concentrators
        • 6.3.3.2.2 Stationary Oxygen Concentrators
      • 6.3.3.3 Nebulizer Therapy Equipment
      • 6.3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 6.3.3.5 Home & Transport Ventilators
  • 6.4 Participant Categorization
  • 6.5 Company Market Position Analysis
    • 6.5.1 Tier 1 (National DME Providers)
    • 6.5.2 Tier 2 (OEM Manufacturers)
    • 6.5.1 Tier 3 (Regional Independents)
  • 6.6 Exit Strategies of Existing Market Players and Their Impact On Market Competitors
    • 6.6.1 Medical Depot, Inc. Dba Drive Devilbiss Healthcare
      • 6.6.1.1 Medical Depot, Inc. dba Drive DeVilbiss Healthcare's Exit Strategy Aims to Realign the Company with its Mission and Vision
      • 6.6.1.2 Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare's exit and its anticipated impact
    • 6.6.2 Philips Respironics
      • 6.6.2.1 Philips Respironics Exit Strategy Stems from Regulatory Pressure, Reputational Impact, And Portfolio Realignment
    • 6.6.3 Fisher & Paykel Healthcare
      • 6.6.3.1 Exit Strategy of Fisher & Paykel Healthcare for F&P Sleep Style CPAP in the U.S.
    • 6.6.4 Invacare
      • 6.6.4.1 Invacare's Exit Strategy Aims to Realign the Company with Its Mission and Vision.
      • 6.6.4.2 Entry of React Health Following Invacare's Exit and Its Anticipated Impact
    • 6.6.5 Resmed
      • 6.6.5.1 ResMed's Exit Strategy from the Portable Oxygen Concentrator (POC) Market
    • 6.6.6 Medtronic
      • 6.6.6.1 Medtronic Exit Strategy
    • 6.6.7 Teleflex Incorporated
      • 6.6.7.1 Teleflex Incorporated Exit Strategy
    • 6.6.8 Breas Medical AB
      • 6.6.8.1 Breas Medical - Exit Strategy for Z1 & Z2 Series CPAP Devices
  • 6.7 Strategy Mapping
    • 6.7.1 Tier 1 (National DME Providers)
      • 6.7.1.1 Mergers and Acquisitions
      • 6.7.1.2 Collaborations & Partnerships
    • 6.7.2 Tier 2 (OEM Manufacturers)
      • 6.7.2.1 New Product Launch
      • 6.7.2.2 Mergers and Acquisitions
      • 6.7.2.3 Other Strategies
    • 6.7.3 Tier 3 (Regional Independents)
      • 6.7.3.1 Mergers and Acquisitions
  • 6.8 List of Other Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Respiratory Durable Medical Equipment Market, by Product Offering, 2021 - 2033 (USD Million)
  • Table 4 U.S. Respiratory Durable Medical Equipment market, by Distribution & Service Channels, 2021 - 2033 (USD Million)
  • Table 5 Reimbursement and Payer Landscape at Each Device Category for Nebraska
  • Table 6 Regulatory & Licensing Framework for Nebraska
  • Table 7 Reimbursement and Payer Landscape at Each Device Category for Iowa
  • Table 8 Regulatory & Licensing Framework for Iowa
  • Table 9 Reimbursement and Payer Landscape at Each Device Category for Kansas
  • Table 10 Regulatory & Licensing Framework for Kansas
  • Table 11 Reimbursement and Payer Landscape at Each Device Category for South Dakota
  • Table 12 Regulatory & Licensing Framework for South Dakota
  • Table 13 Reimbursement and Payer Landscape at Each Device Category for North Dakota
  • Table 14 Regulatory & Licensing Framework for North Dakota
  • Table 15 Reimbursement and Payer Landscape at Each Device Category for Missouri
  • Table 16 Regulatory & Licensing Framework for Missouri
  • Table 17 Reimbursement and Payer Landscape at Each Device Category for Minnesota
  • Table 18 Regulatory & Licensing Framework for Minnesota
  • Table 19 Reimbursement and Payer Landscape for Each Device Category for Wisconsin
  • Table 20 Regulatory & Licensing Framework for Wisconsin
  • Table 21 Reimbursement and Payer Landscape for Each Device Category for Illinois
  • Table 22 Regulatory & Licensing Framework for Illinois
  • Table 23 Reimbursement and Payer Landscape for Each Device Category for Colorado
  • Table 24 Regulatory & Licensing Framework for Colorado
  • Table 25 Reimbursement and Payer Landscape for Each Device Category for Wyoming
  • Table 26 Regulatory & Licensing Framework for Wyoming
  • Table 27 Reimbursement and Payer Landscape for Each Device Category for Ohio
  • Table 28 Regulatory & Licensing Framework for Ohio
  • Table 29 Reimbursement and Payer Landscape for Each Device Category for Indiana
  • Table 30 Regulatory & Licensing Framework for Indiana

List of Figures

  • Fig. 1 U.S. Respiratory DME Market Segmentation
  • Fig. 2 Market snapshot
  • Fig. 3 Product and end use outlook (USD Million)
  • Fig. 4 Competitive landscape
  • Fig. 5 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
  • Fig. 6 U.S. Respiratory Durable Medical Equipment Market by Product Offering :Market Share Analysis, 2025 & 2033
  • Fig. 7 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
  • Fig. 8 Oxygen Therapy Market, 2021 - 2033 (USD Million)
  • Fig. 9 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
  • Fig. 10 Masks, Tubing, Filters & Resupply Items (Consumables) Market 2021 - 2033 (USD Million)
  • Fig. 11 Home & Transport Ventilators Market 2021 - 2033 (USD Million)
  • Fig. 12 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
  • Fig. 13 U.S. Respiratory Durable Medical Equipment Market by Distribution & Service Channels : Market Share Analysis, 2025 & 2033
  • Fig. 14 National DME Networks Market, 2021 - 2033 (USD Million)
  • Fig. 15 Regional Independents Market 2021 - 2033 (USD Million)
  • Fig. 16 Hospital/IDN Homecare Extensions Market 2021 - 2033 (USD Million)
  • Fig. 17 Online DME Retailers Market 2021 - 2033 (USD Million)
  • Fig. 18 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 19 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 20 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 21 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 22 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 23 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 24 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 25 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 26 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 27 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 28 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 29 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 30 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 31 Company/Competition Categorization (Distributors)
  • Fig. 32 Company/Competition Categorization (Manufacturers)
  • Fig. 33 Company Market Position Analysis (Tier 1 (National DME Providers) )
  • Fig. 34 Company Market Position Analysis (Tier 2 (OEM Manufacturers))
  • Fig. 35 Company Market Position Analysis (Tier 3 Regional Independents)
  • Fig. 36 Strategy Mapping (National DME Providers)
  • Fig. 37 Strategy Mapping (OEM Manufacturers)
  • Fig. 38 Strategy mapping (Regional Independents)